Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTMore life to love for patients with certain types of canine CHF. See how different formulations help dog owners manage certain types of CHF in their pets. + Learn More